Work

Sustained disease control with pembrolizumab-lenvatinib in a patient with heavily pre-treated recurrent endometrial carcinoma: a case report

Year: 2025

Type: article

Study design: Case Report

Abstract: Special Issue: https://www.drugsincontext.com/special_issues/new-treatment-options-for-advanced-endometrial-carcinoma.

Source: Drugs in Context

DOI: 10.7573/dic.2025-4-6

Authors: Alessia Lancianese, Elena Maccaroni, Laura Zepponi, Riccardo Giampieri, Rossana Berardi

Institutions: Marche Polytechnic University, Azienda Ospedaliero-Universitaria delle Marche

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,901

OpenAlex ID: W4411413770

FWCI:

Cites:

Cited by:

Related to: 10